Why the study?
Does bishydroxycoumarin (dicumarol) reduce mortality and thromboembolic complications in patients with acute myocardial infarction?
Population
Patients with acute myocardial infarction
Comparison
Bishydroxycoumarin (dicumarol) vs Conventional methods
Design
Editorial
Authors
Loading...
Anticoagulant therapy with dicumarol significantly reduces mortality and thromboembolic complications in acute myocardial infarction compared to conventional management.
Does bishydroxycoumarin (dicumarol) reduce mortality and thromboembolic complications in patients with acute myocardial infarction?
Anticoagulant therapy with dicumarol significantly reduces mortality and thromboembolic complications in acute myocardial infarction compared to conventional management.
Henry I. Russck (1951) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: